Clinical Trial - Diet and Exercise after Pancreatic Cancer - Pancreatic Cancer

As patients usually suffer from weakened body functions, side effects and high motality from pancreatic cancer and its therapies, this research is going to explore how much can pancreatic cancer patients benefit from regular exercise. This research will enroll 50 patients with pancreatic cancer(PACE). One group of the participants will be on diet only, and the other group of patients will be on diet as well as do regular exercise. By using Skype to provide counsels, communicate and gathering data from the fitness bracelet, researchers will get outcomes through comparing the effects of diet alone with diet+exercise. The goal of the study is to advance into an understudied cancer type in the oncology field and develop an intervention that will improve the quality of life of pancreatic cancer patients through distance-delivered counseling methods.

 

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Diet and Exercise After Pancreatic Cancer: Clinical and Functional Outcomes (Non Canonical WNT Signaling in Colorectal Cancer)
Actual Study Start Date : August 3, 2017
Estimated Primary Completion Date : August 31, 2018
Estimated Study Completion Date : August 31, 2019

 

Contacts:

Contact: Laura Q Rogers, MD, MPH 205-975-1667 rogersl@uab.edu
Contact: David Bryan, MS 205-975-1247 dbryan@uab.edu
ClinicalTrials.gov Identifier: NCT03187028

For enrollment please visit www.clinicaltrials.gov

 

 

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.